CompletedPHASE1, PHASE2NCT01281865
Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma
Studying Synovial sarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Mary Louise Keohan, MDMemorial Sloan Kettering Cancer Center
- Intervention
- diagnostic laboratory biomarker analysis(other)
- Enrollment
- 14 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2011 – 2013
Study locations (1)
- Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01281865 on ClinicalTrials.govOther trials for Synovial sarcoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07174427Multi-center Study of TBI-1301 (INN: Mipetresgene Autoleucel; Mip-cel) in Patients With NY-ESO-1 Positive Synovial SarcomaTakara Bio Inc.
- RECRUITINGPHASE1NCT06946225ACTengine® IMA203 Combined With mRNA-4203Immatics US, Inc.
- RECRUITINGNCT05910307Synovial Sarcoma Registry / Biospecimen RepositoryChildren's Hospital of Philadelphia